Investor profile
EMBL Ventures has backed 3 European tech companies across 4 funding rounds between 2015 and 2021, joining rounds totalling €63M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Allecra Therapeutics | Germany | 2 | €37M |
| Topas Therapeutics | Germany | 1 | €18M |
| Luxendo | Germany | 1 | €8.0M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Allecra Therapeutics | Series B | €22M | 2016-06 |
| Topas Therapeutics | Series B | €18M | 2021-07 |
| Allecra Therapeutics | Series A | €15M | 2015-04 |
| Luxendo |
| Series A |
| €8.0M |
| 2017-01 |
